Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestMortgagesNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Newmark (NMRK) Cash & Equivalents (2017 - 2026)

Newmark has reported Cash & Equivalents over the past 9 years, most recently at $229.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 15.89% year-over-year to $229.1 million; the TTM value through Dec 2025 reached $229.1 million, up 15.89%, while the annual FY2025 figure was $229.1 million, 15.89% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $229.1 million at Newmark, up from $224.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $442.8 million in Q1 2022 and troughed at $140.9 million in Q1 2024.
  • A 5-year average of $202.0 million and a median of $185.0 million in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 209.96% in 2022 and later plummeted 52.41% in 2023.
  • Year by year, Cash & Equivalents stood at $191.3 million in 2021, then increased by 21.79% to $233.0 million in 2022, then decreased by 29.23% to $164.9 million in 2023, then increased by 19.89% to $197.7 million in 2024, then rose by 15.89% to $229.1 million in 2025.
  • Business Quant data shows Cash & Equivalents for NMRK at $229.1 million in Q4 2025, $224.1 million in Q3 2025, and $195.8 million in Q2 2025.